Afamelanotide is the primary topic on Retapedia for the
terms listed below. This page distinguishes other meanings and
related entries.
Afamelanotide (also called CUV1647, MT-I, MT-1, Scenesse) may refer to:
Primary topic
- Afamelanotide — Raises skin melanin by activating MC1 receptors. Approved to prevent phototoxic pain in erythropoietic protoporphyria, a rare genetic light sensitivity. Given as a subcutaneous implant.
Also known as
The following names are catalogued aliases for the primary topic:
- CUV1647
- MT-I
- MT-1
- Scenesse
Related entries on Retapedia
- Melanotan II — Stimulates melanin production to darken skin and facilitate tanning. May also increase sexual arousal and reduce appetite. Unapproved for human use; linked to nausea and mole changes.
External meanings
The term CUV1647 may carry meanings outside this catalogue — for example, as a developmental code shared with an unrelated chemical entity, or as a trademarked product name in a different therapeutic area. Retapedia does not catalogue non-peptide compounds; consult an external reference such as PubChem or Wikidata for broader coverage.
Categories:
Disambiguation pages